Results 241 to 250 of about 1,640,663 (265)
Some of the next articles are maybe not open access.
Biomarkers and surrogate end points—the challenge of statistical validation
Nature Reviews Clinical Oncology, 2010Aimery de Gramont +2 more
exaly
Cancer biomarkers: selecting the right drug for the right patient
Nature Reviews Drug Discovery, 2012Gary J Kelloff
exaly
Validation and clinical utility of prostate cancer biomarkers
Nature Reviews Clinical Oncology, 2013Glenn Heller
exaly
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
Nature Reviews Clinical Oncology, 2019Robert Doebele, Keith M Kerr
exaly

